✦ LIBER ✦

Estrogen receptor α gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients

✍ Scribed by Saori Tomita; Zhenhuan Zhang; Masahiro Nakano; Mutsuko Ibusuki; Teru Kawazoe; Yutaka Yamamoto; Hirotaka Iwase

Book ID: 108586430
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 827 KB
Volume: 100
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2009.01145.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen and progesterone receptors in t

Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy

✍ Andrea Manni; Baha'Uddin Arafah; Olof H. Pearson 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 2 views

This review presents our experience with the use of estrogen receptors (ER) and progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV breast cancer. Presence of ER (>3 fmoUmg cytosol protein) significantly predicted response to the antiestrogen tamoxifen and to

Amplification ofESR1may predict resistan

Amplification ofESR1may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

✍ Kirsten Vang Nielsen; Bent Ejlertsen; Sven Müller; Susanne Møller; Birgitte B. R 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 585 KB

Histochemical assay of estrogen and prog

Histochemical assay of estrogen and progesterone receptors in breast cancer: Correlation with biochemical assays and patients' response to endocrine therapies

✍ Louis P. Pertschuk; Ellis H. Tobin; Eric Gaetjens; Anne C. Carter; George A. Deg 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 697 KB

Estrogen (ER) and progesterone (PgR) receptors were assayed by histochemistry in primary, recurrent, and metastatic breast cancer. Ligand-conjugates composed of 17P-estradiol and 1 lcu-hydroxyprogesterone covalently linked to bovine serum albumin and labelled with fluorescein isothiocyanate were emp

PET-based estradiol challenge as a predi

PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer

✍ Farrokh Dehdashti; Joanne E. Mortimer; Kathryn Trinkaus; Michael J. Naughton; Ma 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 221 KB

The CGA gene as new predictor of the res

The CGA gene as new predictor of the response to endocrine therapy in ERα-positive postmenopausal breast cancer patients

✍ Bièche, Ivan; Parfait, Béatrice; Noguès, Catherine; Andrieu, Catherine; Vidaud, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Estrogen receptor immunocytochemistry in

Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol-based ligand-binding assays

✍ Louis P. Pertschuk; Joseph G. Feldman; Yong-Doo Kim; Lorraine Braithwaite; Frank 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

## BACKGROUND. Historically, estrogen receptor (ER) determinations have been made by the ligand-binding assay of tumor homogenates, primarily by the dextrancoated charcoal method (DCC). Irnrnunocytochernical assays (ICA) for ER are more recent and have been executed mostly on frozen sections with t